GRDN
Guardian Pharmacy Services, Inc.
49.98
+0.13 (+0.26%)
52w low 26.34
50.17 high
99.2% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Total Revenue | -- | 908.91M | 1.05B | 1.23B | 1.45B | |
| Cost of Revenue | -- | 723.04M | 837.88M | 984.04M | 1.16B | |
| Gross Profit | -- | 185.87M | 208.31M | 244.37M | 292.72M | |
| Operating Expenses | -- | 133.88M | 167.36M | 307.29M | 220.02M | |
| SG&A | -- | 133.88M | 167.36M | 307.29M | 220.02M | |
| Operating Income | -- | 51.99M | 40.95M | -62.92M | 72.70M | |
| EBITDA | -- | 68.15M | 58.81M | -43.43M | 96.42M | |
| Pretax Income | -- | 49.66M | 37.72M | -66.48M | 73.42M | |
| Income Tax | -- | -- | 0.00 | 4.56M | 24.46M | |
| Net Income | -- | 35.42M | 23.90M | -87.29M | 49.22M | |
| EPS Diluted | -- | 0.58 | 0.00 | -1.77 | 0.78 | |
| Diluted Shares | -- | 60.84M | 60.84M | 62.01M | 63.30M |
Revenue CAGR
+16.8%
Net Income CAGR
+11.6%
EPS CAGR
+10.2%
FCF CAGR
+36.5%
Revenue YoY
+17.9%